Indraprastha Medical Corporation Ltd.
| BSE: 532150 | Sector: Health care |
| NSE: INDRAMEDCO | ISIN Code: INE681B01017 |
| BSE 00:00 | 25 Jan | 54.55 |
-1.60 (-2.85%) |
OPEN
58.40 |
HIGH
58.40 |
LOW
54.25 |
| NSE 00:00 | 25 Jan | 54.60 |
-1.45 (-2.59%) |
OPEN
56.45 |
HIGH
56.80 |
LOW
54.20 |
| OPEN | 58.40 |
| PREVIOUS CLOSE | 56.15 |
| VOLUME | 26850 |
| 52-Week high | 69.80 |
| 52-Week low | 27.45 |
| P/E | |
| Mkt Cap.(Rs cr) | 500 |
| Buy Price | 54.30 |
| Buy Qty | 206.00 |
| Sell Price | 55.00 |
| Sell Qty | 60.00 |
Indraprastha Medical Corporation Ltd. (INDRAMEDCO) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 998.00 | 74.35 | 8.05 | 13266.48 |
| Cipla | 837.10 | 29.05 | 3.60 | 12659.15 |
| Sun Pharma.Inds. | 586.55 | 11.50 | 2.00 | 12531.93 |
| Dr Reddy's Labs | 5082.10 | 48.30 | 0.96 | 11850.40 |
| Lupin | 1081.85 | 2.30 | 0.21 | 11025.66 |
| Apollo Hospitals | 2687.15 | 87.35 | 3.36 | 9794.50 |
| Glenmark Pharma. | 491.30 | -4.00 | -0.81 | 6712.63 |
| Alkem Lab | 3110.05 | 76.25 | 2.51 | 6677.08 |
| Cadila Health. | 466.85 | 6.55 | 1.42 | 6347.40 |
| Torrent Pharma. | 2635.90 | -55.35 | -2.06 | 6168.44 |
| Divi's Lab. | 3570.80 | 26.40 | 0.74 | 5310.57 |
| Ipca Labs. | 1980.90 | -65.05 | -3.18 | 4337.82 |
| Piramal Enterp. | 1466.80 | -20.20 | -1.36 | 4219.19 |
| Alembic Pharma | 960.50 | 19.85 | 2.11 | 4132.55 |
| Abbott India | 14535.90 | 121.45 | 0.84 | 4093.14 |
| Glaxosmi. Pharma | 1488.90 | -28.95 | -1.91 | 3224.68 |
| Jubilant Life | 888.50 | -42.50 | -4.56 | 3139.90 |
| Sanofi India | 8303.45 | -108.95 | -1.30 | 3070.60 |
| Laurus Labs | 379.35 | 8.70 | 2.35 | 2797.34 |
| Gland Pharma | 2249.35 | -33.55 | -1.47 | 2633.24 |
Quick Links for Indraprastha Medical Corporation:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
